# Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine

> **NCT07743008** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **InventVacc Biologicals Inc.** · enrollment: 47 (actual)

## Conditions studied

- Haemophilus Influenzae
- Haemophilus Influenzae Type a

## Interventions

- **BIOLOGICAL:** Haemophilus influenzae serotype a vaccine candidate
- **OTHER:** Saline (as a placebo)

## Key facts

- **NCT ID:** NCT07743008
- **Lead sponsor:** InventVacc Biologicals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-04-29
- **Primary completion:** 2027-02-03
- **Final completion:** 2027-02-03
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2026-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743008, "Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07743008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*